These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
556 related items for PubMed ID: 19183401
1. Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation. Lerche CM, Philipsen PA, Poulsen T, Wulf HC. Exp Dermatol; 2009 Mar; 18(3):246-51. PubMed ID: 19183401 [Abstract] [Full Text] [Related]
2. Topical tacrolimus in combination with simulated solar radiation does not enhance photocarcinogenesis in hairless mice. Lerche CM, Philipsen PA, Poulsen T, Wulf HC. Exp Dermatol; 2008 Jan; 17(1):57-62. PubMed ID: 18095946 [Abstract] [Full Text] [Related]
6. Photocarcinogenesis of topical tazarotene and isotretinoin alone and in combination with valproic acid in hairless mice. Lerche CM, Philipsen PA, Sehested M, Wulf HC. Exp Dermatol; 2008 Nov; 17(11):972-4. PubMed ID: 18616577 [Abstract] [Full Text] [Related]
7. Topical pimecrolimus 1% reverses long-term suberythemal ultraviolet B-induced epidermal Langerhans cell reduction and morphologic changes in mice. Yin Z, Xu J, Lu Y, Luo D. J Drugs Dermatol; 2012 Sep; 11(9):e25-7. PubMed ID: 23135668 [Abstract] [Full Text] [Related]
8. Photocarcinogenesis in hairless mice induced by ultraviolet A tanning devices with or without subsequent solar-simulated ultraviolet irradiation. Bech-Thomsen N, Wulf HC, Poulsen T, Christensen FG, Lundgren K. Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):139-45. PubMed ID: 1814423 [Abstract] [Full Text] [Related]
9. Furocoumarin-induced epidermal melanogenesis does not protect against skin photocarcinogenesis in hairless mice. Kipp C, Lewis EJ, Young AR. Photochem Photobiol; 1998 Jan; 67(1):126-32. PubMed ID: 9477770 [Abstract] [Full Text] [Related]
11. Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin. Ständer S, Ständer H, Seeliger S, Luger TA, Steinhoff M. Br J Dermatol; 2007 May; 156(5):1020-6. PubMed ID: 17388925 [Abstract] [Full Text] [Related]
12. Production and clearance of cyclobutane dipyrimidine dimers in UV-irradiated skin pretreated with 1% pimecrolimus or 0.1% triamcinolone acetonide creams in normal and atopic patients. Doelker L, Tran C, Gkomouzas A, Grand D, Sorg O, Saurat JH, Lübbe J. Exp Dermatol; 2006 May; 15(5):342-6. PubMed ID: 16630073 [Abstract] [Full Text] [Related]
16. Association between exposure to topical tacrolimus or pimecrolimus and cancers. Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, Millares M. Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860 [Abstract] [Full Text] [Related]
17. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease. Zuberbier T, Bräutigam M. J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):718-21. PubMed ID: 18312323 [Abstract] [Full Text] [Related]
18. Treatment with topical khellin in combination with ultraviolet A or solar-simulated radiation is carcinogenic to lightly pigmented hairless mice. Bech-Thomsen N, Wulf HC. Photodermatol Photoimmunol Photomed; 1995 Jun; 11(5-6):204-8. PubMed ID: 8738715 [Abstract] [Full Text] [Related]
19. Pimecrolimus (Elidel, SDZ ASM 981)--preclinical pharmacologic profile and skin selectivity. Stuetz A, Grassberger M, Meingassner JG. Semin Cutan Med Surg; 2001 Dec; 20(4):233-41. PubMed ID: 11770910 [Abstract] [Full Text] [Related]